PhD for the research group “Mucosal Immunology” (m/w/d)

Link: (CompanyWebsite)

Mitarbeiteranzahl: mehr als 10.000 (CompanyEmployee)

Branche: Gesundheitswesen (CompanyIndustry)

Stellenbeschreibung

Anstellungsart

Teilzeit

Arbeitsort

München

Leistungen

Aus der vollständigen Stellenbeschreibung

Reisekostenerstattung

Jobticket

Vollständige Stellenbeschreibung

Campus Innenstadt

Working hours

Part time

Institution

Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital

Department

Forschung / Research, AG Kotlarz

Date of entry

01.07.2026

Application deadline

15.05.2026

Reference Number

2026-K-0139

The Hospital of the University of Munich, Germany, is one of the largest and most competitive university hospitals in Germany and Europe. 48 specialized hospitals, departments and institutions harbouring excellent research and education provide patient care at the highest medical level with around 11.000 employees.

Scope of duties

For a DFG-funded project of the TRR338 “LETSIMMUN” (Lymphocyte Engineering for Therapeutic Synthetic Immunity), the research group “Mucosal Immunology” headed by Prof. Daniel Kotlarz at the Comprehensive Childhood Research Center of the Dr. von Hauner Childrens Hospital (CCRC Hauner) is now offering a position for a highly motivated PhD student.

The overall goal of our interdisciplinary and international research group is to explore molecular causes in children with life-threatening very early onset inflammatory bowel disease (VEO-IBD). In particular, our laboratory focuses on decoding genetic and immune signatures of VEO-IBD by employing omics-based technologies and advanced preclinical models. Our studies will lead to new insights into disease pathogenesis, diagnosis, and treatment for children with this intractable disease.

The project will be conducted at the CCRC-Hauner (130 interdisciplinary scientists) that has an outstanding track record in translational sciences and provides state-of-the-art core facilities (CF) (e.g., NGS, flow cytometry, microscopy). In parallel, we have a bioinformatics team at Helmholtz Munich that supports all projects leveraging advanced multi-omics, computational, and AI-driven infrastructures within the CHC, an emerging European hub for AI-driven precision medicine (40 PIs). Our institutes follows the mission 'Concept Pediatrics – the Child at the Center of Science' exemplifying the interaction of molecular research with patient-oriented clinical applications.

The successful candidate will use innovative viral and CRISPR/Cas9-mediated genome targeting approaches to generate human and mouse CAR Tregs and test their functionality, therapeutic potential, and safety in preclinical disease models, i.e. advanced co-culture models of human immune cells, intestinal organoids and mouse models. The candidate will be introduced into our innovative and advanced experimental pipeline of human disease models including CRISPR/Cas9-mediated genome editing, induced pluripotent stem cells, intestinal organoids and mouse models. The project is integrated in the DFG-funded TRR338 and successful candidates will benefit from the IRTG graduate program.

Our requirements

You are highly motivated and share our enthusiasm for translational science.

You want to help pediatric patients by dissecting disease mechanisms of inflammatory bowel disease.

You are a team player.

You have completed or will soon complete a qualifying degree (Master, Diploma, or similar) in medicine, veterinary medicine, life sciences, pharmacy, or a related discipline.

You have first experience in basic techniques of biochemistry, cellular biology, and molecular biology.